Dr Matthew Hatton is a Consultant Clinical Oncologist and Honorary Reader at the University of Sheffield. He was appointed as Consultant Clinical Oncologist at Weston Park Hospital in 1997. He specialises in the non-surgical treatment of lung and breast cancer and has published widely on advances in the treatment of these malignancies.
Dr Hatton is a member of the NCRI Lung Cancer Study Group (chairing their LORD subgroup), the Clinical Trials Award and Advisory Committee and the Clinical and Translational Radiotherapy Research Group. He chairs the UK Consortium for Stereotactic Ablative Radiotherapy and his research interests include functional imaging for lung cancer radiotherapy and novel radiotherapy fractionations, being principle investigator for a number of national radiotherapy fractionation studies.